Fathom Therapeutics Funding: $47M Raised, Series A (2026)
Fathom Therapeutics is a Biotech company based in New York. It has raised $47M in total funding. Latest round: Series A.
Fathom Therapeutics funding overview
Fathom Therapeutics is a Biotech company based in New York. Fathom Therapeutics has raised $47M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in April 2026. The round record for Fathom Therapeutics runs through 2026; nothing later has been disclosed. Investors on record include Sutter Hill Ventures, Chemistry, Alexandria Venture Investments, NY Ventures. 4 distinct backers are named across the disclosed rounds.
Fathom Therapeutics at a glance
Total raised
$47M
Latest round
Series A
Latest round date
April 2026
Industry
Biotech
Headquarters
New York
Notable investors
Sutter Hill Ventures, Chemistry, Alexandria Venture Investments, NY Ventures
Frequently asked about Fathom Therapeutics funding
How much has Fathom Therapeutics raised?
Fathom Therapeutics has raised $47M in total disclosed funding across the rounds on record.
Who has invested in Fathom Therapeutics?
Sutter Hill Ventures, Chemistry, Alexandria Venture Investments, NY Ventures are named among the investors backing Fathom Therapeutics.
What was the latest Fathom Therapeutics funding round?
The most recent disclosed round is a Series A, announced in April 2026.
Where is Fathom Therapeutics based?
Fathom Therapeutics is based in New York.
What sector does Fathom Therapeutics operate in?
Fathom Therapeutics is tracked under Biotech from New York, with $47M in disclosed funding.
When did Fathom Therapeutics last raise?
The last disclosed Fathom Therapeutics round closed in April 2026 at Series A.
Totals shown for Fathom Therapeutics aggregate every disclosed round on file. To see how that compares, browse the Biotech companies in New York and the investors behind them below.
